metabolic research center tirzepatide (Northside) Tirzepatide vs. Semaglutide: What's the

This supports previous work by researchers at the University of California, Berkeley, and the Children's Hospital Oakland Research Institute led by Professor Bruce Ames

Tirzepatide, known by its brand name Mounjaro, is a once-weekly injection that works by targeting two different receptors in the brain: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor (GLP-1)

It plays a key role in transporting fatty acids into the mitochondria, where they can be converted into usable energy

This equates to: 8.9% of diabetic patients taking semaglutide received a NAION diagnosis

We offer cooking classes and workshops to help you develop the skills needed to maintain a healthy diet

Last reviewed: July 1, 2026 Last updated: July 1, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations